01 · Thesis
A vision for the future, grounded in reality.
Founded in 2023, HEST Ventures backs founders applying visionary science to pressing unmet needs. We seek technical solutions with development strategies that clearly demonstrate value to markets.
We have written the first outside check into many of the companies we’ve backed, and we have the patience to see a project through to the end.
- Life sciences
- Quantum
- Info Tech
- Deep Tech
02 · Team
Disciplined investors with an operator mindset.
HEST is principal-led and personally engaged with every company it backs — decisions are made by the people whose capital is at work, not by committee.
03 · Portfolio
- Life sciencesClinical-stage cell therapy from neonatal cardiac progenitor cells and their secretome. STM-01 holds FDA Fast Track for heart failure (HFpEF).secretometherapeutics.com
- Life sciencesTargeted oncology led by Seagen co-founder Clay Siegall (Nasdaq: IMNM). NDA submitted for varegacestat in desmoid tumors.immunome.com
- Deep techFalcon, Starship, and Starlink — the reusable-launch company that reset the economics of space.spacex.com
- Deep techIntelligent battery components built from aramid nanofibers, spun out of University of Michigan materials research.valerion.energy
- Life sciencesPreclinical melanocortin medicines for obesity and wasting — MC4R and MC3R programs.couragetx.com
- QuantumPost-quantum cryptography for enterprise data in transit — the Ambit Client VPN runs CNSA 2.0-compliant algorithms across every cryptographic component, built for the harvest-now, decrypt-later era.ambit.inc
- Deep techKinetic energy storage on high-temperature superconducting bearings: 2 MW flywheel modules delivering grid inertia, AI data-center ride-through, and fast EV charging.revterra.io
- Life sciencesStealth-stage biopharmaceutical company advancing differentiated medicines for CNS patient populations with high unmet need.arctherapeutics.bio
- Life sciencesTargeted delivery via the body's cholesterol transport system, aimed at tumor metabolism. NIH/NCI Innovative Concept Award.qanatx.com
- Life sciencesVenture studio transforming breakthrough academic science into companies, with ventures spanning RNA therapeutics, exosome immunotherapy, antivirals, cell therapy, and hemostatics.persephonibio.com
- Life sciencesSynthetic, human-identical GM1 ganglioside as the first disease-modifying therapeutic for Parkinson's — built on Phase 2 evidence that GM1 slows progression.renascentneuroscience.com
- Info techAI-driven payment integrity for healthcare — pre-pay review to post-pay recovery in one loop. Founded 2012.claimreturn.com
- Info techAgentic AI platform orchestrating thousands of models and tools into a 24/7 enterprise workforce — automating workflows privately and securely, in minutes rather than weeks. An NVIDIA Inception company.magieva.com
04 · News
- July 15, 2026Persephoni backs SelSym Biotech to bring blood-type-agnostic bleeding control to the point of injuryPersephoni BioPartnersRead
- June 11, 2026Immunome announces first patient dosed in Phase 1 trial of IM-1617, a potential first-in-class ADCImmunomeRead
- May 27, 2026Secretome Therapeutics announces $30M Series A from RA Capital to advance STM-01 for Duchenne-associated cardiomyopathyBusiness WireRead
- November 3, 2025Courage Therapeutics completes seed financing to advance its melanocortin obesity programsCourage TherapeuticsRead
- May 28, 2025Monarch Therapeutics and SNAP Biosciences enter licensing agreement for SNAP-CAR NK cell therapyGlobeNewswireRead
- December 9, 2024Secretome Therapeutics closes $20.4M financing round to advance heart therapiesDallas InnovatesRead
- October 1, 2024HEST Investments partners with Valerion to revolutionize battery technologyPR NewswireRead
- July 19, 2022Revterra raises $6M Series A for its grid-stabilizing kinetic batteryPR NewswireRead